Complete report $1,850. Individual company assessments $250. The companies analyzed in this report include BASF, Cambrex, Clariant, DowPharma, DSM, Evonik, Lanxess, Lonza, Novasep, and Rhodia. For each company, the report presents: • History of the life science intermediates business evolution, important to the understanding of the corporate culture, management mentality and strategies. • Recent acquisitions, divestitures and significant organizational changes. • Current organizational structure. • Background of key executives. Contains 110 pages
|